Valacyclovir neurotoxicity: Clinical experience and review of the literature

T. Asahi*, M. Tsutsui, M. Wakasugi, D. Tange, C. Takahashi, K. Tokui, S. Okazawa, H. Okudera

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

68 Scopus citations

Abstract

Valacyclovir (VACV) is used increasingly to treat herpes zoster, although neuropsychiatric symptoms [VACV neurotoxicity (VAN) or acyclovir neurotoxicity], may accompany use of this drug. To promote awareness of this rare condition, we describe here two clinical cases of VAN we previously reported and review 20 cases from the literature. In all cases, chronic or acute renal failure preceded VAN. The symptoms of VAN varied, but disturbances of consciousness and hallucination occurred most commonly. When acute renal failure was due to the drug, recovery from both the disturbance of consciousness and renal failure followed within several days after discontinuation of VACV. Early recognition and diagnosis will ensure effective treatment of VAN.

Original languageEnglish
Pages (from-to)457-460
Number of pages4
JournalEuropean Journal of Neurology
Volume16
Issue number4
DOIs
StatePublished - 2009/04

Keywords

  • Acyclovir
  • Herpes zoster
  • Neuropsychiatric
  • Neurotoxicity
  • Renal failure
  • Valacyclovir

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Valacyclovir neurotoxicity: Clinical experience and review of the literature'. Together they form a unique fingerprint.

Cite this